TOX: a potential new immune checkpoint in cancers by pancancer analysis.
Shengliang QiuWeiye LinZhengyang ZhouQianran HongShuangyu ChenJiayang LiFengyun ZhongQinfeng ZhouDawei CuiPublished in: Discover oncology (2024)
TOX, a potential biomarker for cancer, may be involved in the regulation of the immune microenvironment and can be used for new targeted drugs.